• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Sangamo Therapeutics, Inc. - Common Stock (NQ:SGMO)

    0.5980 +0.0260 (+4.55%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 4,468,094
    Open 0.5806
    Bid (Size) 0.5980 (33)
    Ask (Size) 0.6076 (10)
    Prev. Close 0.5720
    Today's Range 0.5745 - 0.6219
    52wk Range 0.4111 - 3.179
    Shares Outstanding 145,337,046
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Sangamo Therapeutics Inc (NASDAQ:SGMO) Reports Q2 2025 Earnings: Revenue Misses but Narrower-Than-Expected Loss
    Sangamo Therapeutics (SGMO) reported Q2 2025 results with revenue missing estimates at $18.31M but a narrower loss of $0.08/share. Shares fell 9% post-earnings despite positive Fabry disease trial... 
    Via Chartmill
    Earnings Scheduled For August 7, 2025
     
    Via Benzinga

    Performance

    YTD
    -47.1%
    -47.1%
    1 Month
    -11.2%
    -11.2%
    3 Month
    +11.3%
    +11.3%
    6 Month
    -19.3%
    -19.3%
    1 Year
    -69.9%
    -69.9%

    More News

    Read More
    Tuesday's pre-market session: top gainers and losers
    Via Chartmill
    Sangamo Therapeutics Announces Positive Topline Results From Registrational STAAR Study in Fabry Disease
    From Sangamo Therapeutics, Inc.
    Via Business Wire
    Earnings Scheduled For May 12, 2025
    Via Benzinga
    These stocks are moving in today's session
    Via Chartmill
    Tuesday's session: top gainers and losers
    Via Chartmill
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    There are notable gap-ups and gap-downs in today's session.
    Via Chartmill
    Which stocks are moving before the opening bell on Tuesday?
    Via Chartmill
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    US Stocks Likely To Open Lower After A Strong Rally: 'Lows Are Likely In And Better Times Are Coming,' Says Expert
    Via Benzinga
    Why Coinbase Global Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Which stocks are moving after the closing bell on Monday?
    Via Chartmill
    Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2025 Financial Results
    From Sangamo Therapeutics, Inc.
    Via Business Wire
    Sangamo Therapeutics Announces Pricing of $23.0 Million Underwritten Offering
    From Sangamo Therapeutics, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Sangamo Therapeutics Postpones First Quarter 2025 Conference Call to Later the Same Day
    From Sangamo Therapeutics, Inc.
    Via Business Wire
    Sangamo Therapeutics Announces First Quarter 2025 Earnings Call
    From Sangamo Therapeutics, Inc.
    Via Business Wire
    Sangamo Therapeutics Announces Important Derisking Milestones in Pathway to Anticipated BLA Submission for ST-920 in Fabry Disease
    From Sangamo Therapeutics, Inc.
    Via Business Wire
    Sangamo Therapeutics to Present Neurology Pipeline Advances at the 28th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
    From Sangamo Therapeutics, Inc.
    Via Business Wire
    Friday's pre-market session: top gainers and losers
    Via Chartmill
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    US Stocks Likely To Open Lower After The Worst Selloff Since 2020: Tariff Announcement Was '100% Smoot Hawley Disguised As Thoughtful Policy,' Says Expert
    Via Benzinga
    Topics Government
    Why Sangamo Therapeutics Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket
    Via Benzinga

    Frequently Asked Questions

    Is Sangamo Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Sangamo Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Sangamo Therapeutics, Inc. - Common Stock trade on?
    Sangamo Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Sangamo Therapeutics, Inc. - Common Stock?
    The ticker symbol for Sangamo Therapeutics, Inc. - Common Stock is SGMO on the Nasdaq Stock Market
    What is the current price of Sangamo Therapeutics, Inc. - Common Stock?
    The current price of Sangamo Therapeutics, Inc. - Common Stock is 0.5980
    When was Sangamo Therapeutics, Inc. - Common Stock last traded?
    The last trade of Sangamo Therapeutics, Inc. - Common Stock was at 10/31/25 04:00 PM ET
    What is the market capitalization of Sangamo Therapeutics, Inc. - Common Stock?
    The market capitalization of Sangamo Therapeutics, Inc. - Common Stock is 86.91M
    How many shares of Sangamo Therapeutics, Inc. - Common Stock are outstanding?
    Sangamo Therapeutics, Inc. - Common Stock has 87M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.